Google TrendJONAS BROTHERS (500+) — Jonas Brothers postpone Birmingham concert over weather concerns
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "T-cells and disease statu" (30 stories)

Top Headline Story

T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy
Lead StoryNatureworld
May 15

T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBOWlY2Ym5oczlVNS1hdTJ4SHU3NWhLMkFiWVR3YW5DYWZxNVU4SUhsV2hmYXMzRWxaWFhHQVFrLXB5ZF8tRXNCdUM4aC05WlprQ1lZeGRkOEpwbXhvdGZz?oc=5" target="_blank">T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
500+15m ago

jonas brothers

Jonas Brothers postpone Birmingham concert over weather concerns

500+15m ago

steven kwan

Guardians' Steven Kwan Could Shake Up Winter Outfield Market

200+15m ago

kings vs warriors

3 Storylines I'm Focused On in Warriors Preseason Game vs. Kings

200+15m ago

steffi graf

PICTURES: Steffi Graf & Daughter Jaz Feature In Andre Agassi’s ‘Photo Dump’ As Carlos Alcaraz & Karl-Anthony Towns Make Surprise Appearance

Search Results for "T-cells and disease statu"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
CAR T cell therapy beyond cancer: current status, challenges and future prospects
Naturegeneral

CAR T cell therapy beyond cancer: current status, challenges and future prospects

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE43WVRRMkY3elBIcnp0TUJpV01HNEpabVNXcDY0WldTN3NEbk1faDNmWDdCdHVBNGtkOHlveVJwMnJ3b0dURUVvWV9rLVBKUzhsOVpmVU5LQ2tBNTA5ZVpN?oc=5" target="_blank">CAR T cell therapy beyond cancer: current status, challenges and future prospects</a>  <font color="#6f6f6f">Nature</font>

New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies
CancerNetworkgeneral

New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQc2V5VEpybHZrNVFzVEdDRmRsaEI2NUt2emNyWGlRS3hIbnFwbE5HRmJqaW55M05KcTBHUm1yZUoxYkczcnU2VlozZmhxX1Itd01yVjViWmEyZkdKOEdfQXpRMlpJckRpNTVPdFpPeTd2UlowdU1yb1lsYXU0WGY3bE5SdFFDSkhWUzBGb2V6Xy04YkVRRjlsTTRNUV8zMDNzV09meTZnMXNJQjlPM3hn?oc=5" target="_blank">New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies</a>  <font color="#6f6f6f">CancerNetwork</font>

The European CAR-T map—Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies
Wiley Online Libraryworld

The European CAR-T map—Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBnMzAxbmJWei1DXzVpV2t4bVdyaWRNNkpqbnVSalhIU1FCZElyVFE2TlA2dHo3Mi1pSVFjNEZSTnd3VGx0SDA2WXFSTE9ydmhBWWRveVd3Q0d0UUgtZmFBWkxOX1ZIRjZ3dUkw?oc=5" target="_blank">The European CAR-T map—Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies</a>  <font color="#6f6f6f">Wiley Online Library</font>

FDA Grants Orphan Drug Status to CTD402 for Rare T-Cell Blood Cancers
Cure Todaygeneral

FDA Grants Orphan Drug Status to CTD402 for Rare T-Cell Blood Cancers

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPZXBSZWZnbjFUMUUxU2hXZGVtNnpKRm1BUnplUktJdjZoQ2x0MVR2VW1KN2gxMExWNHBIWWVKSDB3bktfSlh6ZEczRER0SlYzRXpDWmJnZHBtNk9ZU2c1RVMyRHlPZnNDQnBuYl9uVGc4WTJOVWFOR1g5OGltOUl4ZU16bnVEdHFYX05XckFWTmg1UFJpdG9vRVdZY08?oc=5" target="_blank">FDA Grants Orphan Drug Status to CTD402 for Rare T-Cell Blood Cancers</a>  <font color="#6f6f6f">Cure Today</font>

FDA awards breakthrough device status to sickle cell diagnostic test
Sickle Cell Disease Newsgeneral

FDA awards breakthrough device status to sickle cell diagnostic test

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOcjRzRzdnNGQwc2hVbGlXamt5N2hMTnh3TkQyNUJ2X2xRWWZSZHVUYkRyOXNxZ2U0ZUUtSUJ0OF9lbVlQa1drT2UtSDlSaEdGVG9yNmpWRzFscUdMaHVERzNKbTZranprVkN3R2FqOFJBWHhsYVlVTUl6bFU5c0d4ZW4zLXlVMElTLWNOZDJKZFczeXVsaGlhYkNISktFb1FZRzhr?oc=5" target="_blank">FDA awards breakthrough device status to sickle cell diagnostic test</a>  <font color="#6f6f6f">Sickle Cell Disease News</font>

T-cell therapy CK0803 earns FDA orphan drug designation for ALS
ALS News Todaygeneral

T-cell therapy CK0803 earns FDA orphan drug designation for ALS

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQVWMzZVFMTC15LXVCNjBoM2JiVm00S0FpU19FTXdWdUp2amhDMndTNTFqSmdYOEZJQk1ESkZBZmlVTHB5VU5fSnFFRERheUVIREZiclZ0MWtMR0FJejJYTndtVVN4RXEtaVQ3TFU4enF6Tm1Lem11bVVWNFpzTkVSdm40V2I0R0RxWmIxak9LQWJOYTRn?oc=5" target="_blank">T-cell therapy CK0803 earns FDA orphan drug designation for ALS</a>  <font color="#6f6f6f">ALS News Today</font>

Immunotherapy of chimeric antigen receptor NK cells: status and its promising future
Frontiersworld

Immunotherapy of chimeric antigen receptor NK cells: status and its promising future

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOUElKLXhLRkJkQzAxbmRfaU9IczB6aGIxcWsyQWg5RWpLSVNLZHBkaXc1bEMtZjNueFlqWU9yMlBzYmV5aWI0M2xtU3h0M2htRmdJeHYxNGNHZTZLZ1ItbEtRSkNYbEgyUDdtc2xDN0pZa2RSVC1TQnBkTjRPcVlORmt5aWxwQTN6Zl9vdjZkaVFBZw?oc=5" target="_blank">Immunotherapy of chimeric antigen receptor NK cells: status and its promising future</a>  <font color="#6f6f6f">Frontiers</font>

Disease diagnostics using machine learning of B cell and T cell receptor sequences
Science | AAASgeneral

Disease diagnostics using machine learning of B cell and T cell receptor sequences

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9NSTBsOE1najJxZm9rT2dRaUFVY29qYWpsek0zTGl5dE1nNXNhcGRpZTlQOWhEQU9jV2c4cUNCM096UE96c0ZNRTczYnduQVJIZFJjN0w5TExMR1NKT0hiWA?oc=5" target="_blank">Disease diagnostics using machine learning of B cell and T cell receptor sequences</a>  <font color="#6f6f6f">Science | AAAS</font>

Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy | Bone Marrow Transplantation
Natureworld

Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy | Bone Marrow Transplantation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1kcGQxbmpKSTBndFA3MVZxVGcybmhSUlB2UWtKSjdFYWxwVVNRUTNrWEl1Y3Z3VnZLTkJ5OGJOdWlDYWc4QWk3ZHFZcExvUndNd09fRUh5NkdSVV8zcUY4?oc=5" target="_blank">Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy | Bone Marrow Transplantation</a>  <font color="#6f6f6f">Nature</font>

CD8 memory T cells and TGF-β have changed their relationship status to “it’s complicated.”
Fred Hutchinson Cancer Research Centergeneral

CD8 memory T cells and TGF-β have changed their relationship status to “it’s complicated.”

<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE9XQWNmOHhsR1hMSTFsQWFRelYxNjFVcHh0eTVJMHJ4VnVxRHFCanliLTFWSjNkWTJYTUNpOFhCT3RDWkdYSl9hTGhpSjl2UFBoeEszc2JETEtod1MtNVlqbkhvNWpVYWN1dHFkNlJ5eERsNHRvY1JGTk1QS00?oc=5" target="_blank">CD8 memory T cells and TGF-β have changed their relationship status to “it’s complicated.”</a>  <font color="#6f6f6f">Fred Hutchinson Cancer Research Center</font>

Dietary Betaine Improves Immune Function, Antioxidant Status, Immune‐Related Signaling Molecules, and Disease Resistance in Fish Species - Yousefi - 2025 - Aquaculture Nutrition
Wiley Online Librarytech

Dietary Betaine Improves Immune Function, Antioxidant Status, Immune‐Related Signaling Molecules, and Disease Resistance in Fish Species - Yousefi - 2025 - Aquaculture Nutrition

<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE9VV2p1b2d4YnhSZ3pfcDl5ZUd1eFhjVTJDaFFVQ1JOd29RNE4xR29BSjl1dEFwZEtlYk9hejhQRDNzUngwU3VuWE5wUF96ZHlTWm04YWYwZ2FaWFYwS1UyUDYySlY2UQ?oc=5" target="_blank">Dietary Betaine Improves Immune Function, Antioxidant Status, Immune‐Related Signaling Molecules, and Disease Resistance in Fish Species - Yousefi - 2025 - Aquaculture Nutrition</a>  <font color="#6f6f6f">Wiley Online Library</font>

CAR-T cell therapy clinical trials: global progress, challenges, and future directions from ClinicalTrials.gov insights
Frontiersgeneral

CAR-T cell therapy clinical trials: global progress, challenges, and future directions from ClinicalTrials.gov insights

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPRHowVmJveTY0NnozLV9QUWZJX0pPaldSTEd4U3pwd2lvLUc1SUtGa3FOMkZ6T3ZORGg1Um93Y2hPbnBRd29nY0stMWl6c2RrNTRoSEdpVm5tUDhsMENyV0JMZndBeGEtYjZxaExjUkJmSFVNVWJONkg2bHl1bk9fZnBia0FPM1IzUVU3M1k4S3dJZw?oc=5" target="_blank">CAR-T cell therapy clinical trials: global progress, challenges, and future directions from ClinicalTrials.gov insights</a>  <font color="#6f6f6f">Frontiers</font>

Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID
Natureworld

Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1JVFdJZGUyZTZxbHk5SmRXQWI0YTd1a3psRFVJXy1YUHh5Qi0yWHV0WDRVX3YycnkzWGZUZjFVZUROTXhKWGE1TlJ5ZVVGYldzNDk4NG5mTnNKSjI3SldV?oc=5" target="_blank">Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID</a>  <font color="#6f6f6f">Nature</font>

T cell exhaustion is associated with cognitive status and amyloid accumulation in Alzheimer’s disease
Naturegeneral

T cell exhaustion is associated with cognitive status and amyloid accumulation in Alzheimer’s disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5LLU5rNEhCbFY1ZnJSMzJxZTNZTG91ZGZVc0FDYlRldlhOVkt2QW1uS0JlbGhULUhUZ1IxMGt5Nk9TQ1VrTnJDYjVkREZwUUVJdERrVjdQeXdaelkycThZ?oc=5" target="_blank">T cell exhaustion is associated with cognitive status and amyloid accumulation in Alzheimer’s disease</a>  <font color="#6f6f6f">Nature</font>

CAR-T cell therapy in Multiple Myeloma: current status and future challenges | Blood Cancer Journal
Naturegeneral

CAR-T cell therapy in Multiple Myeloma: current status and future challenges | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBpNVJMOWptcmpPV3BBRG5QeERCellyMl9DQ2JpZ2dMY0VqanNPVFBSeUdyWDRsc09EWUVzNS1KZE5qYm1weXlVNExuWU1JQ040SXE0NXBIeWxtOEdVTFRV?oc=5" target="_blank">CAR-T cell therapy in Multiple Myeloma: current status and future challenges | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Social status impacts T-cell responses through synapse strength in the prefrontal cortex
Naturegeneral

Social status impacts T-cell responses through synapse strength in the prefrontal cortex

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE90LTY3T3JvMG9Qc2tHQVYxVEN3eFQ5a2NYVDhlellrTkZZRThGbFZyTk9zbGhHcWNwZkQ1S3ZoOUtJRlEzdXpfQXBlSUFjcDlkY19jUDJiazZJR0trNlo0?oc=5" target="_blank">Social status impacts T-cell responses through synapse strength in the prefrontal cortex</a>  <font color="#6f6f6f">Nature</font>

The transition between M1 and M2 macrophage phenotypes is associated with the disease status following CD19 CAR-T therapy for B cell lymphoma/leukemia
Naturegeneral

The transition between M1 and M2 macrophage phenotypes is associated with the disease status following CD19 CAR-T therapy for B cell lymphoma/leukemia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0zVW5wUmMwUHdicXNwejdGLWxLa0xuNEJmNWVKSUkxVkJxSkp4bmw3WVMyNWhINHJ0engxSzg2elJfSFZKbE81NFJwM1RTOWlXOHN5d2NqakMtN3ExZlFB?oc=5" target="_blank">The transition between M1 and M2 macrophage phenotypes is associated with the disease status following CD19 CAR-T therapy for B cell lymphoma/leukemia</a>  <font color="#6f6f6f">Nature</font>

Chromatin accessibility of circulating CD8⁺ T cells differentiates disease severity in IgA nephropathy
Naturegeneral

Chromatin accessibility of circulating CD8⁺ T cells differentiates disease severity in IgA nephropathy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5ZcEVZLTNReFJsTnQ0S1c3VWVDNk5nNEZ0TEd1UEpfTkI1ZE1DQWpSUFpUemYyWlhkYUV3ZEhoU05oTXVDV0dSRzhObDU4NmI1UklIdlIycXpWMUtTSXRR?oc=5" target="_blank">Chromatin accessibility of circulating CD8⁺ T cells differentiates disease severity in IgA nephropathy</a>  <font color="#6f6f6f">Nature</font>

Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
Naturegeneral

Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB1aU5Db05TNnNicmdKR2pJT05EY2RSVVd3TWVXQm9wWThqRm5ETS1oM2ZKRHdGd0RmUkxKNnhSTk9QTEdiVnNVaXB2dnotWGJGVnc0X01YVmdQbEM3TkUw?oc=5" target="_blank">Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients</a>  <font color="#6f6f6f">Nature</font>

Specific immune status in Parkinson’s disease at different ages of onset
Natureworld

Specific immune status in Parkinson’s disease at different ages of onset

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE12TGNNcFppOF9qQjFwWS02ZVBic2hCVVRyTHExTU1xQ0VZQTdhSTRJdlZTMndLd1FjanFQWU5SY2xvOUZnbExkeU9qUWlfWUszNnlTWGY0UHdndnRNY1Y0?oc=5" target="_blank">Specific immune status in Parkinson’s disease at different ages of onset</a>  <font color="#6f6f6f">Nature</font>

T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy
Natureworld

T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE50VjQxQVExVnhla3l1eXR4ZlpsdHdIWlpQc0prUnQ3UHluY2RVOFNpZmROZlhfbXJ3RExGRG84STA2WHNDQjIwWUQ3T0VwR0hQWkpBbm8tamg1dEozaWNN?oc=5" target="_blank">T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy</a>  <font color="#6f6f6f">Nature</font>

A systems immunology analysis of Alzheimer's disease reveals an age- and environmental exposure-independent disturbance in B cell maturation
Wiley & Sonsworld

A systems immunology analysis of Alzheimer's disease reveals an age- and environmental exposure-independent disturbance in B cell maturation

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE9XZllfWDJsZG9QODQ5N0NjYl9NX0pRVkhndUdYcWxfMndzWTdObE9HV0hqd1h1eUUxVE5DXzhVcVlZdVZNYndYdGxvWnkzWmFQMWFDZk1tOVB5SHBlS1lkREx0b0JBYm9xREJGUkdZYk9yampMeVNUem9kcw?oc=5" target="_blank">A systems immunology analysis of Alzheimer's disease reveals an age- and environmental exposure-independent disturbance in B cell maturation</a>  <font color="#6f6f6f">Wiley & Sons</font>

Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signatures
Natureworld

Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signatures

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9KOGNleHROUnMwZnJBTl9YZjBsRDgzaTl4SDJGSUo0OUFILXl4THNIemZnRUJLSEgyTHozTWZkTXBvWTFEc0lWV3B3aGtmTThGOWJmLU1tLWJXaGlaNFVn?oc=5" target="_blank">Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signatures</a>  <font color="#6f6f6f">Nature</font>

Adaptive immune dysregulation drives new-onset refractory status epilepticus
Frontiersworld

Adaptive immune dysregulation drives new-onset refractory status epilepticus

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQZEJVemp3NXZKYXpTcnJiaFpTUjM5ZE9RQ3F5SEJLdkhjUHBMeTBkTm84MmNSM1FnVFNyX2VDemttYXZCLXZIQmEzZkFXa3FDb0xxcFN6b2o5dThVWUxLY1JpaGZndWRRNzhmQjAwTzREY3lKVkpkUUlJdXo1ODJmLWNLZnp2WWwtcWROM3pHeWxrUQ?oc=5" target="_blank">Adaptive immune dysregulation drives new-onset refractory status epilepticus</a>  <font color="#6f6f6f">Frontiers</font>

T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy
Naturetech

T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBjNHM1T0F0RE5EenI1RGwzVkFPem9XWGJqYmE4WUgxa1A5N1pNaGdKcWRGSERaeldoa2tGcWh4b2J6a3ZybjVqSExIcWdWSVZBcWs2SE5PalI2UGZXcUVJ?oc=5" target="_blank">T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy</a>  <font color="#6f6f6f">Nature</font>

Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinoma
Naturegeneral

Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0cDIxNVp3M2hwS21iZ1dKMHBFNlppb004cUY2MzdYMDRDSVBLV3N1SEdUNFBTSmdiYnd5VGR0QTR3Y2J1eWJEQ0RUQzNKY01UbHRqNHB0dkcyeU0xd0hB?oc=5" target="_blank">Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinoma</a>  <font color="#6f6f6f">Nature</font>

Dynamic monitoring of lymphocyte subsets at different disease stages can predict the prognosis of acute myeloid leukemia especially in complete remission status
Naturegeneral

Dynamic monitoring of lymphocyte subsets at different disease stages can predict the prognosis of acute myeloid leukemia especially in complete remission status

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5vSkRkbUxVdWlPNnJPWVdtem1IUGZkM21XNVY0a3ZYelZwQmJ5b1ZvR2hDcFlDbUhwdEt4dFRXbDE3RXpUT3VmWTVPZHhBQ1lPamtlRmxtWnpjY19HVndF?oc=5" target="_blank">Dynamic monitoring of lymphocyte subsets at different disease stages can predict the prognosis of acute myeloid leukemia especially in complete remission status</a>  <font color="#6f6f6f">Nature</font>

Mixed T-cell chimerism at 3 months predicts late relapse in acute myeloid leukemia after allogeneic stem cell transplantation
Naturegeneral

Mixed T-cell chimerism at 3 months predicts late relapse in acute myeloid leukemia after allogeneic stem cell transplantation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE83Y3JEUTFnV1BpRzVHR0hVRVZaY1ozRmVJcG5qLVVEUFM0SF9DMzM0MzlHcHpUdm5jYkhkZWRWWlRHVC13VjNldlp0djBMcThhX3lyVTNSMFNvV2hyd1Mw?oc=5" target="_blank">Mixed T-cell chimerism at 3 months predicts late relapse in acute myeloid leukemia after allogeneic stem cell transplantation</a>  <font color="#6f6f6f">Nature</font>

Stem cell therapy in Alzheimer’s disease: current status and perspectives
Frontiersgeneral

Stem cell therapy in Alzheimer’s disease: current status and perspectives

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPYzZEUTJQTnltNlkyR0ctWWszQlMta2V2TFl4M05CMGpVRGVLY1Rsa1dRRDVyc2FKZFZTY3FZd2NVQmJkVFkwSUJmYUl3ZW81Q3RMaGJ2T0dnN2RMN2tyZ2E1TDRIVXN0TF9QaVhNenpzVFFHUDZWTm1MUUdQN0Q3XzVSQlVCT0pZbFM5cE5XdWI4dTFZ?oc=5" target="_blank">Stem cell therapy in Alzheimer’s disease: current status and perspectives</a>  <font color="#6f6f6f">Frontiers</font>

"T-cells and disease statu" — Live Google News Trends & Headlines